LILLY FDA Approval NDA 021086

NDA 021086

LILLY

FDA Drug Application

Application #021086

Documents

Letter2000-04-06
Letter2006-09-18
Letter2006-03-01
Letter2007-07-10
Letter2009-11-19
Letter2010-02-01
Letter2010-06-03
Letter2010-06-03
Letter2010-12-06
Letter2011-06-27
Letter2013-07-30
Label2006-02-28
Label2006-12-04
Label2009-03-20
Label2007-07-10
Label2009-09-17
Label2010-01-29
Label2010-06-03
Label2010-12-04
Label2011-06-29
Label2013-07-30
Label2015-07-24
Review2000-04-06
Letter2005-09-15
Letter2006-12-28
Letter2007-07-10
Letter2008-08-19
Letter2011-06-27
Letter2014-12-23
Label2000-04-06
Label2006-08-29
Label2007-07-10
Label2010-06-03
Label2011-06-29
Label2015-01-09
Other Important Information from FDA2011-12-22
Letter2016-10-14
Label2016-10-07
Label2017-02-27
Label2017-02-27
Letter2017-03-02
Letter2017-03-02
Label2018-03-28
Letter2018-03-29
Letter2019-10-23
Label2019-10-24
Medication Guide2019-10-24
Letter2020-04-22
Label2020-04-22
Medication Guide2020-04-22
Label2020-04-24
Medication Guide2020-04-24
Letter2020-04-24

Application Sponsors

NDA 021086LILLY

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001TABLET, ORALLY DISINTEGRATING;ORAL5MG1ZYPREXA ZYDISOLANZAPINE
002TABLET, ORALLY DISINTEGRATING;ORAL10MG1ZYPREXA ZYDISOLANZAPINE
003TABLET, ORALLY DISINTEGRATING;ORAL15MG1ZYPREXA ZYDISOLANZAPINE
004TABLET, ORALLY DISINTEGRATING;ORAL20MG1ZYPREXA ZYDISOLANZAPINE

FDA Submissions

TYPE 3; Type 3 - New Dosage FormORIG1AP2000-04-06STANDARD
MANUF (CMC); Manufacturing (CMC)SUPPL3AP2001-10-24STANDARD
LABELING; LabelingSUPPL9AP2006-02-16STANDARD
LABELING; LabelingSUPPL11AP2006-08-25STANDARD
LABELING; LabelingSUPPL13AP2006-02-16STANDARD
LABELING; LabelingSUPPL15AP2005-09-13STANDARD
LABELING; LabelingSUPPL16AP2006-02-23STANDARD
LABELING; LabelingSUPPL20AP2006-11-29STANDARD
EFFICACY; EfficacySUPPL21AP2009-03-19PRIORITY
LABELING; LabelingSUPPL22AP2007-07-06STANDARD
LABELING; LabelingSUPPL23AP2007-07-06STANDARD
LABELING; LabelingSUPPL28AP2008-08-14STANDARD
LABELING; LabelingSUPPL30AP2009-08-31UNKNOWN
LABELING; LabelingSUPPL31AP2010-01-27UNKNOWN
LABELING; LabelingSUPPL32AP2010-05-27UNKNOWN
LABELING; LabelingSUPPL34AP2010-05-27UNKNOWN
LABELING; LabelingSUPPL36AP2010-12-01901 REQUIRED
REMS; REMSSUPPL38AP2011-06-21N/A
REMS; REMSSUPPL39AP2011-06-21N/A
LABELING; LabelingSUPPL40AP2014-12-19STANDARD
EFFICACY; EfficacySUPPL41AP2013-07-26STANDARD
LABELING; LabelingSUPPL42AP2015-07-23STANDARD
LABELING; LabelingSUPPL43AP2016-10-06901 REQUIRED
LABELING; LabelingSUPPL44AP2017-02-23STANDARD
LABELING; LabelingSUPPL45AP2017-02-23901 REQUIRED
LABELING; LabelingSUPPL46AP2018-03-27STANDARD
LABELING; LabelingSUPPL47AP2019-10-22STANDARD
LABELING; LabelingSUPPL48AP2020-04-23STANDARD
LABELING; LabelingSUPPL49AP2020-04-21901 REQUIRED

Submissions Property Types

ORIG1Null31
SUPPL3Null0
SUPPL21Null4
SUPPL22Null4
SUPPL30Null6
SUPPL31Null6
SUPPL32Null6
SUPPL34Null6
SUPPL36Null6
SUPPL38Null7
SUPPL39Null6
SUPPL40Null6
SUPPL41Null7
SUPPL42Null7
SUPPL43Null15
SUPPL44Null6
SUPPL45Null6
SUPPL46Null6
SUPPL47Null33
SUPPL48Null15
SUPPL49Null6

TE Codes

001PrescriptionAB
002PrescriptionAB
003PrescriptionAB
004PrescriptionAB

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 21086
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.